Obi Pharma Inc.
OBI Pharma, Inc., a clinical‑stage oncology innovator from Taipei, advances a multi‑product pipeline targeting triple‑negative breast cancer, NSCLC, HCC, and solid tumors, with phase 3, 2, and 1 candidates, while also engaging in pharmaceutical trade and R&D.
Headquarters: Taiwan (TWN)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical and Diagnostic Laboratories
- HQ: Taipei
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.